Product Information
OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB is a generic product labeled by Ascend Laboratories, LLC, priced at $0.1817 per EA under NDC 67877045390. Its NADAC has been published 51 times since Jul 9, 2025.
OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDEStrength
12.5; 20 mg/1; mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877045390
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA207037On Market Since
5/1/2025
Pharmacological Classes
Price Statistics
The NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has been published 51 times since Jul 9, 2025, and over the history we have for it it has declined 9.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1817 per EA |
|---|---|
| All-time high | $0.1999 (Jul 16, 2025) |
| All-time low | $0.1669 (Feb 18, 2026) |
| 52-week high | $0.1999 |
| 52-week low | $0.1669 |
| Median price | $0.1691 |
| Average price | $0.1758 |
| Largest weekly change | -10.0% (Sep 17, 2025) |
| Weeks tracked | 51 |
| Tracking since | Jul 9, 2025 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB, manufactured by Ascend Laboratories, LLC, is $0.1817 per EA (NDC 67877045390), effective Jun 24, 2026.
How has the price of OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB changed over time?
Over the history we have for it, the NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has declined 9.1%. It has been tracked across 51 weekly CMS publications since Jul 9, 2025.
What are the highest and lowest recorded NADAC prices for OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
Since Jul 9, 2025, the NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has ranged from a low of $0.1669 (Feb 18, 2026) to a high of $0.1999 (Jul 16, 2025), with a median of $0.1691 per EA.
Are there cheaper alternatives to OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB, is $0.1751 per EA — about 4% below OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB.
Who manufactures OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB (NDC 67877045390) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification